A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks
Latest Information Update: 22 Dec 2021
At a glance
- Drugs Givosiran (Primary)
- Indications Acute intermittent porphyria; Hereditary coproporphyria; Variegate-porphyria
- Focus Therapeutic Use
- Acronyms EXPLORE
- Sponsors Alnylam Pharmaceuticals
Most Recent Events
- 27 Oct 2021 Results of EXPLORE Part B presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021
- 14 May 2021 Status changed from active, no longer recruiting to completed.
- 18 Feb 2021 Planned End Date changed from 1 Oct 2023 to 1 May 2021.